Riverwater Partners’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-101,996
Closed -$2.55M 215
2024
Q3
$2.55M Buy
101,996
+86,037
+539% +$2.23M 1.27% 15
2024
Q2
$404K Sell
15,959
-1,703
-10% -$44.1K 0.3% 102
2024
Q1
$449K Sell
17,662
-46
-0.3% -$1.11K 0.33% 87
2023
Q4
$401K Buy
17,708
+111
+0.6% +$2.3K 0.32% 95
2023
Q3
$328K Buy
17,597
+7,813
+80% +$162K 0.3% 113
2023
Q2
$254K Hold
9,784
0.23% 151
2023
Q1
$281K Buy
9,784
+6
+0.1% +$179 0.26% 127
2022
Q4
$289K Buy
+9,778
New +$278K 0.25% 131
2022
Q3
Sell
-12,466
Closed -$278K 189
2022
Q2
$278K Buy
12,466
+96
+0.8% +$2.14K 0.28% 127
2022
Q1
$311K Buy
12,370
+3,274
+36% +$99.8K 0.51% 81
2021
Q4
$326K Buy
+9,096
New +$364K 0.29% 133

Other funds holding ANIK